Finance

Lists
600276:SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
46,63 CNY
+0,06%
(+0,030) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600276...
Open
46,25 CNY
High
47,58 CNY
Low
45,51 CNY
Mkt. cap
297,26 მლრ.
Avg. vol.
59,82 მლნ.
Volume
68,74 მლნ.
Dividend
0,43%
Quarterly dividend
0,05 CNY
Ex-dividend date
27 მაი. 2026
P/E ratio
40,02
52-wk high
68,50 CNY
52-wk low
41,89 CNY
EPS
1,17 CNY
Shares outstanding
3,68 მლრდ.
No. of employees
21 ათ.
Open
46,25 CNY
High
47,58 CNY
Low
45,51 CNY
Mkt. cap
297,26 მლრ.
Avg. vol.
59,82 მლნ.
Volume
68,74 მლნ.
Dividend
0,43%
Quarterly dividend
0,05 CNY
Ex-dividend date
27 მაი. 2026
P/E ratio
40,02
52-wk high
68,50 CNY
52-wk low
41,89 CNY
EPS
1,17 CNY
Shares outstanding
3,68 მლრდ.
No. of employees
21 ათ.
News stories
From web sources and news partners
Trefis
Trefis
·
21 წუთის წინ
1 S&P 500 Stock Hit A 52-Week Low On Friday
Simply Wall Street
Simply Wall Street
·
21 წუთის წინ
What AAON Bears Saw Before The Fall
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees20,7 ათ.
Founded1970
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
7,43 მლრდ.
8,44 მლრდ.
8,14 მლრდ.
7,32 მლრდ.
Cost of goods sold
1,07 მლრდ.
1,25 მლრდ.
1,09 მლრდ.
1,02 მლრდ.
Cost of revenue
1,07 მლრდ.
1,25 მლრდ.
1,09 მლრდ.
1,02 მლრდ.
Research and development expenses
1,72 მლრდ.
2,02 მლრდ.
1,65 მლრდ.
1,84 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,23 მლრდ.
3,01 მლრდ.
2,81 მლრდ.
2,78 მლრდ.
Operating expense
4,76 მლრდ.
5,35 მლრდ.
4,48 მლრდ.
4,61 მლრდ.
Total operating expenses
5,83 მლრდ.
6,60 მლრდ.
5,57 მლრდ.
5,63 მლრდ.
Operating income
1,60 მლრდ.
1,84 მლრდ.
2,57 მლრდ.
1,68 მლრდ.
Other non operating income
-154,21 მლნ.
145,74 მლნ.
-345,12 მლნ.
243,91 მლნ.
EBT including unusual items
1,36 მლრდ.
2,30 მლრდ.
2,56 მლრდ.
2,40 მლრდ.
EBT excluding unusual items
1,68 მლრდ.
1,91 მლრდ.
2,55 მლრდ.
1,60 მლრდ.
Income tax expense
55,51 მლნ.
338,85 მლნ.
275,87 მლნ.
211,27 მლნ.
Effective tax rate
4,08%
14,76%
10,79%
8,82%
Other operating expenses
-217,30 მლნ.
326,84 მლნ.
4,76 მლნ.
-5,09 მლნ.
Net income
1,30 მლრდ.
1,96 მლრდ.
2,28 მლრდ.
2,18 მლრდ.
Net profit margin
17,52%
23,22%
28,04%
29,84%
Earnings per share
0,20
-
-
-
Interest and investment income
242,14 მლნ.
288,66 მლნ.
322,96 მლნ.
448,28 ათ.
Interest expense
-689,68 ათ.
-2,00 მლნ.
-448,28 ათ.
-322,96 მლნ.
Net interest expenses
241,45 მლნ.
286,66 მლნ.
322,52 მლნ.
-322,52 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,78 მლრდ.
2,04 მლრდ.
2,77 მლრდ.
1,93 მლრდ.
Gain or loss from assets sale
2,31 მლნ.
-4,05 მლნ.
-
-40,62 მლნ.
AI content may include mistakes. Learn more
Google აპები